N/A
N=71
Evaluation of Wear Experience With One Week Reusable Contact Lenses in Habitual Two Week Reusable Lens Wearers
Myopia
Bottom Line
View on ClinicalTrials.gov: NCT06382064 ↗Enrolled (actual)
71
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcome: Primary: Subjective Assessment of Lens Wear Experience — 10 Scores on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Biweekly replacement contact lenses (Device); One week replacement contact lenses (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Ohio State University
- Primary completion
- Dec 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Subjective Assessment of Lens Wear Experience |
10 | — |
Summary
This open-label study is of current Acuvue® Oasys® wearers (2 - week replacement, reusable lenses) who are satisfied with their current lenses. Subjects will be refit into one week reusable contact lenses and will wear lenses for approximately 2 weeks. Subjects will return for vision and lens fit assessments and will complete surveys about their wear experience.
Eligibility Criteria
Inclusion Criteria
- At least 18 years of age
- Ability to give informed consent
- Current Acuvue® Oasys® spherical lens wearer.
- Distance visual acuity of 20/25 or better with current contact lenses in each eye.
- Good general health defined by, medication use that has not changed within the last 30 days and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the Investigator.
- Willing to spend time for the study, which includes: attend three study visits and wear contact lenses on days between study visits.
Exclusion Criteria
- Current or active ocular inflammation or infection as determined by the Investigator.
- Currently pregnant or lactating. (Participants will be asked to self-report these conditions).
- Systemic inflammatory disease (i.e. Diabetes, etc.) that could confound study results in the opinion of the investigator.
Data sourced from ClinicalTrials.gov (NCT06382064). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.